Walleye Capital
NVCR icon

Walleye Capital’s NovoCure NVCR Stock Holding History

Walleye Capital’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.3K Buy
+1,535
New +$23.2K ﹤0.01% 4358
2026
Q1 		– Sell
-11,676
Closed -$151K – 4794
2025
Q4 		$151K Sell
11,676
-205,117
-95% -$2.63M ﹤0.01% 3679
2025
Q3 		$2.8M Buy
216,793
+204,975
+1,734% +$2.74M 0.01% 1336
2025
Q2 		$210K Buy
+11,818
New +$206K ﹤0.01% 3324
2025
Q1 		– Sell
-23,878
Closed -$712K – 4853
2024
Q4 		$712K Buy
23,878
+21,961
+1,146% +$465K ﹤0.01% 2684
2024
Q3 		$30K Sell
1,917
-8,281
-81% -$150K ﹤0.01% 4742
2024
Q2 		$175K Sell
10,198
-41,502
-80% -$730K ﹤0.01% 4401
2024
Q1 		$808K Sell
51,700
-60,383
-54% -$888K ﹤0.01% 2786
2023
Q4 		$1.67M Sell
112,083
-23,564
-17% -$315K ﹤0.01% 1925
2023
Q3 		$2.19M Buy
135,647
+95,647
+239% +$2.76M 0.01% 1670
2023
Q2 		$1.66M Buy
+40,000
New +$2.48M 0.01% 1457
2023
Q1 		– Sell
-7,308
Closed -$584K – 4237
2022
Q4 		$536K Buy
+7,308
New +$550K 0.01% 1406
2022
Q3 		– Sell
-2,972
Closed -$232K – 3438
2022
Q2 		$207K Buy
+2,972
New +$224K 0.01% 1507
2020
Q4 		– Sell
-2,128
Closed -$237K – 1055
2020
Q3 		$237K Buy
+2,128
New +$170K 0.03% 564
2019
Q4 		– Sell
-8,204
Closed -$613K – 2115
2019
Q3 		$613K Sell
8,204
-1,529
-16% -$122K 0.04% 654
2019
Q2 		$615K Buy
9,733
+8,223
+545% +$417K 0.07% 418
2019
Q1 		$73K Buy
+1,510
New +$72.7K 0.01% 1119

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Walleye Capital's NVCR Position: Q2 2026 in Review

Walleye Capital opened a new position in NovoCure (NVCR) in Q2 2026: 1,535 shares worth $23.3K. The stake represents ﹤0.01% of the portfolio and ranks #4358 among its holdings. This is a return to the name: Walleye Capital previously reported a position in NVCR as recently as Q4 2025.

Walleye Capital first reported a position in NVCR in Q1 2019 and has held it in 17 quarters since. The position peaked at $2.8M in Q3 2025. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Walleye Capital held 1,535 shares of NovoCure worth $23.3K as of Q2 2026.
  • NovoCure was a new Walleye Capital position in Q2 2026.
  • NovoCure made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4358 holding.
  • Walleye Capital first reported a position in NovoCure in Q1 2019 and has held it in 17 quarters since.
  • Walleye Capital's NovoCure position peaked at $2.8M in Q3 2025.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.